Clinical notes

Is Belbuca the Same as Suboxone? Buprenorphine Products Compared

Clinical Notes

No. Belbuca and Suboxone both contain buprenorphine, but they are different products for different conditions. Belbuca is a buccal film with a low dose of buprenorphine alone, approved in the US for chronic pain. Suboxone is a sublingual film combining a much higher dose of buprenorphine with naloxone, approved for opioid use disorder. Sublocade and Brixadi are long-acting buprenorphine injections, also for opioid use disorder. They aren’t interchangeable, and they shouldn’t be taken together.

By Dr. Ema HudsonUpdated: October 20264 min read

Illustration: Belbuca vs Suboxone – Canfora Medicine Guide

The short answer

  • Same molecule, different products: all contain buprenorphine, a partial opioid agonist.
  • Belbuca: chronic pain; micrograms of buprenorphine, every 12 hours.
  • Suboxone: opioid use disorder; milligrams of buprenorphine plus naloxone, once daily.
  • Sublocade / Brixadi: opioid use disorder; injections weekly or monthly, given by a clinician.
  • Don’t combine them, and don’t switch without the prescriber.

Side-by-side comparison

Belbuca Suboxone Sublocade Brixadi
Ingredients Buprenorphine Buprenorphine + naloxone (4:1) Buprenorphine extended-release Buprenorphine extended-release
Form Film stuck to the inside of the cheek Film under the tongue (generic tablets also exist) Subcutaneous injection Subcutaneous injection
US approval Chronic pain needing daily long-term opioid Opioid use disorder Moderate to severe opioid use disorder Moderate to severe opioid use disorder
Strengths 75 to 900 micrograms 2/0.5 to 12/3 mg 100 mg and 300 mg Weekly and monthly formulations
How often Every 12 hours Once daily Monthly (at least 26 days apart) Weekly or monthly
Who gives it Patient Patient Clinician only, REMS-certified setting Clinician only, REMS-certified setting

The scale is the key difference: the maximum Belbuca dose (900 micrograms twice a day) is about 1.8 mg of buprenorphine a day, while common Suboxone maintenance doses are 8–16 mg a day or more. US information, Stand: November 2026; brands and approvals differ elsewhere (in the UK and Australia, buprenorphine for opioid dependence is given as sublingual tablets, Espranor wafers or Buvidal injections, and buprenorphine for pain mainly as patches).

Why Suboxone contains naloxone and Belbuca doesn’t

Naloxone is an opioid blocker that is poorly absorbed under the tongue. Taken as directed, it does almost nothing. If someone dissolves and injects Suboxone, the naloxone becomes active and can trigger withdrawal, which discourages misuse. Belbuca is a pain medicine with a much lower buprenorphine dose, so it doesn’t include naloxone.

Can one be used instead of the other?

  • Belbuca for opioid use disorder: not approved, and its doses are far too low to control cravings and withdrawal for most people with OUD.
  • Suboxone for pain: sometimes used off-label by specialists, usually in divided doses, but it isn’t approved for pain in the US.
  • Switching from full opioids to either: buprenorphine can cause precipitated withdrawal if started while full agonists (oxycodone, morphine, fentanyl) are still active. The prescriber decides the timing or uses a specific low-dose start.
  • Taking both together: duplicates the same drug and increases sedation and breathing risk, with no benefit. Don’t.

Safety points common to all buprenorphine products

  • Sedatives: combining with benzodiazepines, alcohol, gabapentinoids or sleep aids increases the risk of slowed breathing. See tramadol and gabapentin for the same principle.
  • Heart rhythm: Belbuca’s label warns about QT prolongation at higher doses.
  • Dental problems: the FDA added a warning in 2022 about tooth decay with buprenorphine dissolved in the mouth; rinse with water after the film dissolves and see a dentist regularly.
  • Keep out of reach of children: a single film can be fatal to a child.
  • Naloxone rescue: people on any opioid, including buprenorphine, should keep naloxone (Narcan) at home.

Who can prescribe buprenorphine for OUD (US)

Since the Consolidated Appropriations Act of 2023 removed the “X-waiver”, any practitioner with a current DEA registration that includes Schedule III can prescribe buprenorphine for opioid use disorder. Sublocade and Brixadi are dispensed only to certified healthcare settings under their REMS programs. More practical notes are in our clinical pharmacy guide.

Call 911 if someone taking buprenorphine is very hard to wake, breathing slowly or has blue lips, and give naloxone if available. For questions about switching products, talk to the prescriber; don’t change on your own.

Frequently asked questions

Is Belbuca stronger than Suboxone?

No. Belbuca contains much less buprenorphine per dose (micrograms vs milligrams).

Is Sublocade the same as Suboxone?

Both treat opioid use disorder with buprenorphine, but Sublocade is a monthly injection without naloxone, given by a clinician; Suboxone is a daily film you take yourself.

Can I take Belbuca with Suboxone?

No. They contain the same drug, and combining them adds risk without benefit.

Will Belbuca show up as Suboxone on a drug test?

Tests that look for buprenorphine detect both. Only Suboxone contains naloxone, which some labs also test for.

More on this topic: more practical prescribing and administration notes are collected in Clinical Pharmacy Notes: Practical Reference for Nurses and Pharmacists.

Medical disclaimer: this article is general information, not a diagnosis or a personal recommendation. Check with your doctor or pharmacist before starting, stopping or combining medicines. Read the full disclaimer.

Back to the clinical notes guide